Sign up to save your podcasts
Or
Share FDA Advisory Committee to Consider Tofersen…
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Advisory Committee to Consider Tofersen…
This week Jeremy talks to Dr. Neil Thakur about The ALS Association’s comments to the FDA urging them to approve tofersen, a gene therapy targeting SOD1 mutations. He then digs into the tofersen clinical trials with lead investigator Dr. Timothy Miller.
For more information on genetic testing and counseling go to https://www.als.org/understanding-als/who-gets-als/genetic-testing
This episode is brought to you by The ALS Association in partnership with CitizenRacecar.
View all episodes
By ALS Association
4.7
4949 ratings
This week Jeremy talks to Dr. Neil Thakur about The ALS Association’s comments to the FDA urging them to approve tofersen, a gene therapy targeting SOD1 mutations. He then digs into the tofersen clinical trials with lead investigator Dr. Timothy Miller.
For more information on genetic testing and counseling go to https://www.als.org/understanding-als/who-gets-als/genetic-testing
This episode is brought to you by The ALS Association in partnership with CitizenRacecar.